Abstract
Malignant ureteral stricture is caused by ureteral compression by tumor invasion or tumor metastasis to the retroperitoneum, and upper urinary tract symptoms are caused by tumor factors. Imaging examination revealed hydroureter and hydronephrosis, which may lead to renal region pain and upper urinary tract infections, even renal failure. Severity of the disease could lead to the death of the patient. Patients with malignant ureteral strictures have worse prognosis and less survival time. Clinically, there are no relevant guidelines for the diagnosis and management of malignant ureteral strictures, and diversified therapy procedures exist, yet none of them are the most suitable. Most malignant ureteral stricture patients do not tolerate open surgery. With the development and continuously maturing of endoluminal techniques, the use of minimally invasive surgery has also become more mature; more therapy options are expected to have improved over time for malignant ureteral stricture patients. The use of ureteric stents is common in the treatment of benign or malignant ureteric strictures because the features of good durability facilitate urine drainage and structurally support the vascular wall. This review article will be based on advances in ureteral stents in the maintenance therapeutic of malignant ureteral strictures.
Similar content being viewed by others
Data Availability
The data presented in this study are available on reasonable request from the corresponding author.
References
Kurata S, Tobu S, Udo K et al (2017) Outcomes of ureteral stent placement for hydronephrosis in patients with gynecological malignancies[J]. Curr Urol 10(3):126–131. https://doi.org/10.1159/000447165
Hsu L, Li H, Pucheril D et al (2016) Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction[J]. World J Nephrol 5(2):172–181. https://doi.org/10.5527/wjn.v5.i2.172
Tyritzis SI, Wiklund NP (2015) Ureteral strictures revisited…trying to see the light at the end of the tunnel: a comprehensive review[J]. J Endourol 29(2):124–136. https://doi.org/10.1089/end.2014.0522
Vogt B, Blanchet LH (2021) 10-year experience with reinforced ureteral stents for malignant ureteral obstruction[J]. Res Rep Urol 13:581–589. https://doi.org/10.2147/RRU.S326274
Cordeiro MD, Coelho RF, Chade DC et al (2016) A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients[J]. BJU Int 117(2):266–271. https://doi.org/10.1111/bju.12963
Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin 66(4):271–289. https://doi.org/10.3322/caac.21349
Yoon JH, Park S, Park S et al (2018) Renal function is associated with prognosis in stent-change therapy for malignant ureteral obstruction[J]. Investig Clin Urol 59(6):376–382. https://doi.org/10.4111/icu.2018.59.6.376
Maguire PJ, Sobota A, Mulholland D et al (2020) Incidence, management, and sequelae of ureteric obstruction in women with cervical cancer[J]. Support Care Cancer 28(2):725–730. https://doi.org/10.1007/s00520-019-04851-9
O’Connor EM, Nason GJ, Kiely EA (2017) Urological management of extramural malignant ureteric obstruction: a survey of Irish urologists[J]. Curr Urol 11(1):21–25. https://doi.org/10.1159/000447190
Zimskind PD, Fetter TR, Wilkerson JL (1967) Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically[J]. J Urol 97(5):840–844. https://doi.org/10.1016/s0022-5347(17)63130-6
Rosevear HM, Kim SP, Wenzler DL et al (2007) Retrograde ureteral stents for extrinsic ureteral obstruction: nine years’ experience at University of Michigan[J]. Urology 70(5):846–850. https://doi.org/10.1016/j.urology.2007.07.008
Wang Y, Wang G, Hou P et al (2015) Subcutaneous nephrovesical bypass: treatment for ureteral obstruction in advanced metastatic disease[J]. Oncol Lett 9(1):387–390. https://doi.org/10.3892/ol.2014.2679
Shekarriz B, Shekarriz H, Upadhyay J et al (1999) Outcome of palliative urinary diversion in the treatment of advanced malignancies[J]. Cancer 85(4):998–1003. https://doi.org/10.1002/(sici)1097-0142(19990215)85:4%3c998::aid-cncr30%3e3.0.co;2-f
Chung SY, Stein RJ, Landsittel D et al (2004) 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents[J]. J Urol 172(2):592–595. https://doi.org/10.1097/01.ju.0000130510.28768.f5
Yossepowitch O, Lifshitz DA, Dekel Y et al (2001) Predicting the success of retrograde stenting for managing ureteral obstruction[J]. J Urol 166(5):1746–1749. https://doi.org/10.1097/00005392-200111000-00029
Wang JY, Zhang HL, Zhu Y et al (2016) Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients[J]. Oncol Lett 11(1):879–883. https://doi.org/10.3892/ol.2015.3961
Ganatra AM, Loughlin KR (2005) The management of malignant ureteral obstruction treated with ureteral stents[J]. J Urol 174(6):2125–2128. https://doi.org/10.1097/01.ju.0000181807.56114.b7
Izumi K, Mizokami A, Maeda Y et al (2011) Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction[J]. J Urol 185(2):556–561. https://doi.org/10.1016/j.juro.2010.09.102
Goldsmith ZG, Wang AJ, Bañez LL et al (2012) Outcomes of metallic stents for malignant ureteral obstruction[J]. J Urol 188(3):851–855. https://doi.org/10.1016/j.juro.2012.04.113
Wenzler DL, Kim SP, Rosevear HM et al (2008) Success of ureteral stents for intrinsic ureteral obstruction[J]. J Endourol 22(2):295–299. https://doi.org/10.1089/end.2007.0201
Ohtaka M, Kawahara T, Takamoto D et al (2018) Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure[J]. BMC Urol 18(1):35. https://doi.org/10.1186/s12894-018-0346-3
Matsuura H, Arase S, Hori Y (2019) Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure[J]. Int J Clin Oncol 24(3):306–312. https://doi.org/10.1007/s10147-018-1348-6
Kim SH, Park B, Joo J et al (2017) Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction[J]. PLoS One 12(9):e0184965. https://doi.org/10.1371/journal.pone.0184965
Matsuura H, Arase S, Hori Y (2020) Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction[J]. Support Care Cancer 28(12):5743–5750. https://doi.org/10.1007/s00520-020-05413-0
Elsamra SE, Motato H, Moreira DM et al (2013) Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy[J]. J Endourol 27(10):1297–1302. https://doi.org/10.1089/end.2013.0281
Savin Z, Herzberg H, Ben-David R et al (2021) Long-term follow-up of yearly replaced double internal stents for extrinsic malignant ureteral obstruction[J]. J Endourol 35(1):71–76. https://doi.org/10.1089/end.2020.0469
Haifler M, Shvero A, Zilberman D et al (2020) Tandem ureteral stents for malignant ureteral obstruction[J]. J Endourol 34(2):222–226. https://doi.org/10.1089/end.2019.0685
Varnavas M, Bolgeri M, Mukhtar S et al (2016) The role of tandem double-J ureteral stents in the management of malignant ureteral obstruction[J]. J Endourol 30(4):465–468. https://doi.org/10.1089/end.2015.0670
Liu KL, Lee BC, Ye JD et al (2019) Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients[J]. Eur Radiol 29(2):628–635. https://doi.org/10.1007/s00330-018-5560-6
Monsky WL, Molloy C, Jin B et al (2013) Quality-of-life assessment after palliative interventions to manage malignant ureteral obstruction[J]. Cardiovasc Intervent Radiol 36(5):1355–1363. https://doi.org/10.1007/s00270-013-0571-9
Ku JH, Lee SW, Jeon HG et al (2004) Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?[J]. Urology 64(5):895–899. https://doi.org/10.1016/j.urology.2004.06.029
Guachetá-Bomba PL, Echeverría-García F, García-Perdomo HA (2021) Predictors for failure of endoscopic ureteric stenting in patients with malignant ureteric obstruction: systematic review and meta-analysis[J]. BJU Int 127(3):292–299. https://doi.org/10.1111/bju.15237
Donat SM, Russo P (1996) Ureteral decompression in advanced nonurologic malignancies[J]. Ann Surg Oncol 3(4):393–399. https://doi.org/10.1007/bf02305670
Hao P, Li W, Song C et al (2008) Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases: report of 2685 cases[J]. J Endourol 22(1):65–70. https://doi.org/10.1089/end.2007.0114
Newton MR, Brown JA (2011) Full-length metallic double J stents: a review of Resonance® stents[J]. Clin Med Insights: Urol 5:S6604. https://doi.org/10.4137/CMU.S6604
Azizi A, Pasticier G, Bénard A et al (2012) Tolerance and effectiveness of Memokath® 051 ureteral stents: a prospective 3 year follow-up study[J]. Prog Urol 22(5):266–272. https://doi.org/10.1016/j.purol.2012.01.002
Agrawal S, Brown CT, Bellamy EA et al (2009) The thermo-expandable metallic ureteric stent: an 11-year follow-up[J]. BJU Int 103(3):372–376. https://doi.org/10.1111/j.1464-410X.2008.08018.x
Chow PM, Hsu JS, Huang CY et al (2014) Metallic ureteral stents in malignant ureteral obstruction: clinical factors predicting stent failure[J]. J Endourol 28(6):729–734. https://doi.org/10.1089/end.2013.0792
Liatsikos E, Kallidonis P, Kyriazis I et al (2010) Ureteral obstruction: is the full metallic double-pigtail stent the way to go?[J]. Eur Urol 57(3):480–486. https://doi.org/10.1016/j.eururo.2009.02.004
Asakawa J, Iguchi T, Tamada S et al (2018) Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction[J]. Int J Urol 25(3):258–262. https://doi.org/10.1111/iju.13500
Miyazaki J, Onozawa M, Takahashi S et al (2019) The Resonance ® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study[J]. BMC Urol 19(1):137. https://doi.org/10.1186/s12894-019-0569-y
Kang Q, Jiang F, Yu Y et al (2018) Application of resonance metallic stents for malignant ureteral obstruction[J]. Minim Invasive Ther Allied Technol 27(6):333–338. https://doi.org/10.1080/13645706.2018.1443944
Chen Y, Liu CY, Zhang ZH et al (2019) Malignant ureteral obstruction: experience and comparative analysis of metallic versus ordinary polymer ureteral stents[J]. World J Surg Oncol 17(1):74. https://doi.org/10.1186/s12957-019-1608-6
Moskovitz B, Halachmi S, Nativ O (2012) A new self-expanding, large-caliber ureteral stent: results of a multicenter experience[J]. J Endourol 26(11):1523–1527. https://doi.org/10.1089/end.2012.0279
Author information
Authors and Affiliations
Contributions
LL: conception and design of the work, manuscript writing, manuscript revision, and checking of all data. YX: manuscript writing, manuscript revision, and checking of all data. FS: manuscript revision and checking of all data. QW: manuscript revision and checking of all data.
Corresponding author
Ethics declarations
Ethics Approval
Ethics approval was not required for this study.
Consent for Publication
Not required.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, L., Xiao, Y., Sun, Fz. et al. Advances in Ureteral Stents in the Maintenance Therapeutic of Malignant Ureteral Stricture. Indian J Surg (2023). https://doi.org/10.1007/s12262-023-03916-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12262-023-03916-8